Literature DB >> 28149852

Circulating microRNA biomarkers for cardiovascular risk prediction: are we approaching clinical application?

Maurice W J de Ronde1, Yigal M Pinto2, Sara-Joan Pinto-Sietsma1.   

Abstract

Year:  2016        PMID: 28149852      PMCID: PMC5233531          DOI: 10.21037/atm.2016.12.05

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  12 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Analytical challenges and technical limitations in assessing circulating miRNAs.

Authors:  Anna Zampetaki; Manuel Mayr
Journal:  Thromb Haemost       Date:  2012-05-25       Impact factor: 5.249

3.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

4.  miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome.

Authors:  Min Guo; Xiaobo Mao; Qingwei Ji; Mingjian Lang; Songnan Li; Yudong Peng; Wei Zhou; Bo Xiong; Qiutang Zeng
Journal:  Immunol Cell Biol       Date:  2010-03-02       Impact factor: 5.126

5.  Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR.

Authors:  Maayke G M Kok; Amalia Halliani; Perry D Moerland; Joost C M Meijers; Esther E Creemers; Sara-Joan Pinto-Sietsma
Journal:  FASEB J       Date:  2015-05-28       Impact factor: 5.191

6.  Plasma microRNA 499 as a biomarker of acute myocardial infarction.

Authors:  Taichi Adachi; Michio Nakanishi; Yoritaka Otsuka; Kunihiro Nishimura; Gou Hirokawa; Yoichi Goto; Hiroshi Nonogi; Naoharu Iwai
Journal:  Clin Chem       Date:  2010-04-15       Impact factor: 8.327

7.  Assessment of microRNAs in patients with unstable angina pectoris.

Authors:  Tanja Zeller; Till Keller; Francisco Ojeda; Tobias Reichlin; Raphael Twerenbold; Stergios Tzikas; Philipp S Wild; Miriam Reiter; Ewa Czyz; Karl J Lackner; Thomas Munzel; Christian Mueller; Stefan Blankenberg
Journal:  Eur Heart J       Date:  2014-04-11       Impact factor: 29.983

8.  Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.

Authors:  Mahir Karakas; Christian Schulte; Sebastian Appelbaum; Francisco Ojeda; Karl J Lackner; Thomas Münzel; Renate B Schnabel; Stefan Blankenberg; Tanja Zeller
Journal:  Eur Heart J       Date:  2017-02-14       Impact factor: 29.983

Review 9.  MicroRNAs in cardiovascular disease: an introduction for clinicians.

Authors:  Simon P R Romaine; Maciej Tomaszewski; Gianluigi Condorelli; Nilesh J Samani
Journal:  Heart       Date:  2015-03-26       Impact factor: 5.994

10.  Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina.

Authors:  Yuri D'Alessandra; Maria Cristina Carena; Liana Spazzafumo; Federico Martinelli; Beatrice Bassetti; Paolo Devanna; Mara Rubino; Giancarlo Marenzi; Gualtiero I Colombo; Felice Achilli; Stefano Maggiolini; Maurizio C Capogrossi; Giulio Pompilio
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more
  2 in total

1.  Pre-amplification as a method for improvement of quantitative RT-PCR analysis of circulating miRNAs.

Authors:  Ankica Sekovanić; Adrijana Dorotić; Jasna Jurasović; Daria Pašalić; Jelena Kovačić; Sandra Stasenko; Tatjana Mioč; Martina Piasek; Tatjana Orct
Journal:  Biochem Med (Zagreb)       Date:  2020-12-15       Impact factor: 2.313

2.  MicroRNA profiling in plasma samples using qPCR arrays: Recommendations for correct analysis and interpretation.

Authors:  Andreas B Gevaert; Isabel Witvrouwen; Christiaan J Vrints; Hein Heidbuchel; Emeline M Van Craenenbroeck; Steven J Van Laere; Amaryllis H Van Craenenbroeck
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.